Capricor Therapeutics, Inc. (CAPR)
31.68
-0.43
(-1.34%)
USD |
NASDAQ |
Apr 06, 16:00
31.50
-0.18
(-0.57%)
After-Hours: 20:00
Capricor Therapeutics SG&A Expense (TTM) : 23.69M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | 32.68M |
| Vaxart, Inc. | 17.61M |
| Allogene Therapeutics, Inc. | 56.78M |
| REGENXBIO, Inc. | 82.86M |
| Replimune Group, Inc. | 103.07M |